ProShare Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-284
Closed -$50.2K 1921
2023
Q1
$50.2K Sell
284
-36
-11% -$6.37K ﹤0.01% 1669
2022
Q4
$124K Buy
320
+23
+8% +$8.9K ﹤0.01% 1604
2022
Q3
$100K Buy
297
+8
+3% +$2.69K ﹤0.01% 1561
2022
Q2
$95K Sell
289
-137
-32% -$45K ﹤0.01% 1621
2022
Q1
$186K Sell
426
-89
-17% -$38.9K ﹤0.01% 1901
2021
Q4
$226K Buy
515
+29
+6% +$12.7K ﹤0.01% 1957
2021
Q3
$270K Sell
486
-116
-19% -$64.4K ﹤0.01% 1620
2021
Q2
$310K Buy
602
+106
+21% +$54.6K ﹤0.01% 1875
2021
Q1
$388K Buy
496
+29
+6% +$22.7K ﹤0.01% 1631
2020
Q4
$254K Buy
467
+117
+33% +$63.6K ﹤0.01% 1721
2020
Q3
$160K Sell
350
-13
-4% -$5.94K ﹤0.01% 1454
2020
Q2
$224K Buy
+363
New +$224K ﹤0.01% 1403
2020
Q1
Sell
-430
Closed -$250K 1628
2019
Q4
$250K Sell
430
-45
-9% -$26.2K ﹤0.01% 1456
2019
Q3
$313K Buy
475
+57
+14% +$37.6K ﹤0.01% 1210
2019
Q2
$324K Sell
418
-53
-11% -$41.1K ﹤0.01% 1200
2019
Q1
$332K Buy
471
+4
+0.9% +$2.82K ﹤0.01% 1199
2018
Q4
$218K Sell
467
-89
-16% -$41.5K ﹤0.01% 1332
2018
Q3
$479K Buy
556
+75
+16% +$64.6K ﹤0.01% 1124
2018
Q2
$332K Sell
481
-33
-6% -$22.8K ﹤0.01% 1321
2018
Q1
$229K Sell
514
-84
-14% -$37.4K ﹤0.01% 1470
2017
Q4
$264K Buy
+598
New +$264K ﹤0.01% 1476
2016
Q4
Sell
-536
Closed -$161K 1755
2016
Q3
$161K Sell
536
-100
-16% -$30K ﹤0.01% 1376
2016
Q2
$110K Buy
636
+13
+2% +$2.25K ﹤0.01% 1514
2016
Q1
$140K Sell
623
-66
-10% -$14.8K ﹤0.01% 1481
2015
Q4
$418K Buy
689
+61
+10% +$37K 0.01% 1122
2015
Q3
$323K Buy
628
+63
+11% +$32.4K ﹤0.01% 1113
2015
Q2
$247K Buy
565
+26
+5% +$11.4K ﹤0.01% 1392
2015
Q1
$195K Buy
539
+88
+20% +$31.8K ﹤0.01% 1726
2014
Q4
$162K Buy
+451
New +$162K ﹤0.01% 1781